Rank | Gene Set | Z-score |
---|---|---|
1 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 6.55649827 |
2 | L-phenylalanine catabolic process (GO:0006559) | 6.55649827 |
3 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 6.42121639 |
4 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 6.42121639 |
5 | L-phenylalanine metabolic process (GO:0006558) | 6.31402906 |
6 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 6.31402906 |
7 | aromatic amino acid family catabolic process (GO:0009074) | 5.96822077 |
8 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.72001324 |
9 | glyoxylate metabolic process (GO:0046487) | 5.55514604 |
10 | indole-containing compound catabolic process (GO:0042436) | 5.47544981 |
11 | indolalkylamine catabolic process (GO:0046218) | 5.47544981 |
12 | tryptophan catabolic process (GO:0006569) | 5.47544981 |
13 | kynurenine metabolic process (GO:0070189) | 5.39809432 |
14 | urea cycle (GO:0000050) | 5.31666483 |
15 | urea metabolic process (GO:0019627) | 5.31666483 |
16 | bile acid biosynthetic process (GO:0006699) | 5.28483754 |
17 | negative regulation of fibrinolysis (GO:0051918) | 5.25420667 |
18 | high-density lipoprotein particle remodeling (GO:0034375) | 5.25226289 |
19 | disruption of cells of other organism (GO:0044364) | 5.24629026 |
20 | killing of cells of other organism (GO:0031640) | 5.24629026 |
21 | sulfur amino acid catabolic process (GO:0000098) | 5.19001385 |
22 | tryptophan metabolic process (GO:0006568) | 5.09332798 |
23 | alpha-linolenic acid metabolic process (GO:0036109) | 5.07744122 |
24 | regulation of fibrinolysis (GO:0051917) | 5.00706230 |
25 | protein carboxylation (GO:0018214) | 4.98319782 |
26 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.98319782 |
27 | regulation of protein activation cascade (GO:2000257) | 4.97768603 |
28 | complement activation, alternative pathway (GO:0006957) | 4.97239625 |
29 | protein-lipid complex remodeling (GO:0034368) | 4.95431931 |
30 | macromolecular complex remodeling (GO:0034367) | 4.95431931 |
31 | plasma lipoprotein particle remodeling (GO:0034369) | 4.95431931 |
32 | nitrogen cycle metabolic process (GO:0071941) | 4.88240153 |
33 | cysteine metabolic process (GO:0006534) | 4.87778259 |
34 | regulation of triglyceride catabolic process (GO:0010896) | 4.75434818 |
35 | imidazole-containing compound metabolic process (GO:0052803) | 4.72951212 |
36 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.65007032 |
37 | regulation of complement activation (GO:0030449) | 4.64351225 |
38 | low-density lipoprotein particle remodeling (GO:0034374) | 4.61930355 |
39 | reverse cholesterol transport (GO:0043691) | 4.61097556 |
40 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 4.54415880 |
41 | serine family amino acid catabolic process (GO:0009071) | 4.46605262 |
42 | bile acid metabolic process (GO:0008206) | 4.41794489 |
43 | glycine metabolic process (GO:0006544) | 4.37332110 |
44 | aromatic amino acid family metabolic process (GO:0009072) | 4.30197171 |
45 | amino-acid betaine metabolic process (GO:0006577) | 4.25994046 |
46 | regulation of cholesterol esterification (GO:0010872) | 4.25787974 |
47 | phospholipid efflux (GO:0033700) | 4.19246051 |
48 | serine family amino acid biosynthetic process (GO:0009070) | 4.18097757 |
49 | alpha-amino acid catabolic process (GO:1901606) | 4.13173202 |
50 | homocysteine metabolic process (GO:0050667) | 4.07033245 |
51 | serine family amino acid metabolic process (GO:0009069) | 4.04911476 |
52 | plasma lipoprotein particle clearance (GO:0034381) | 4.04587836 |
53 | triglyceride homeostasis (GO:0070328) | 4.04490398 |
54 | acylglycerol homeostasis (GO:0055090) | 4.04490398 |
55 | aggressive behavior (GO:0002118) | 4.01990248 |
56 | negative regulation of sterol transport (GO:0032372) | 4.01044111 |
57 | negative regulation of cholesterol transport (GO:0032375) | 4.01044111 |
58 | tyrosine metabolic process (GO:0006570) | 3.99986394 |
59 | lysine metabolic process (GO:0006553) | 3.99905140 |
60 | lysine catabolic process (GO:0006554) | 3.99905140 |
61 | plasma lipoprotein particle assembly (GO:0034377) | 3.92771209 |
62 | aldehyde catabolic process (GO:0046185) | 3.87975008 |
63 | plasma lipoprotein particle organization (GO:0071827) | 3.87129122 |
64 | defense response to fungus (GO:0050832) | 3.85734275 |
65 | cellular amino acid catabolic process (GO:0009063) | 3.81898092 |
66 | cholesterol efflux (GO:0033344) | 3.78455675 |
67 | cellular modified amino acid catabolic process (GO:0042219) | 3.76173250 |
68 | cellular ketone body metabolic process (GO:0046950) | 3.75929232 |
69 | cellular glucuronidation (GO:0052695) | 3.75019229 |
70 | fibrinolysis (GO:0042730) | 3.74521991 |
71 | indolalkylamine metabolic process (GO:0006586) | 3.74361718 |
72 | bile acid and bile salt transport (GO:0015721) | 3.74100853 |
73 | immunoglobulin mediated immune response (GO:0016064) | 3.71997761 |
74 | cellular biogenic amine catabolic process (GO:0042402) | 3.70902101 |
75 | amine catabolic process (GO:0009310) | 3.70902101 |
76 | positive regulation of B cell differentiation (GO:0045579) | 3.70514451 |
77 | phospholipid homeostasis (GO:0055091) | 3.68678779 |
78 | glutamate metabolic process (GO:0006536) | 3.68419294 |
79 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.66615241 |
80 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.66615241 |
81 | coenzyme catabolic process (GO:0009109) | 3.64513628 |
82 | protein-lipid complex subunit organization (GO:0071825) | 3.63535447 |
83 | benzene-containing compound metabolic process (GO:0042537) | 3.63047402 |
84 | ethanol oxidation (GO:0006069) | 3.60417532 |
85 | blood coagulation, intrinsic pathway (GO:0007597) | 3.59084585 |
86 | regulation of mast cell degranulation (GO:0043304) | 3.54624711 |
87 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.53383629 |
88 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.52543828 |
89 | regulation of superoxide anion generation (GO:0032928) | 3.52225018 |
90 | protein-lipid complex assembly (GO:0065005) | 3.51510760 |
91 | positive regulation of lipid catabolic process (GO:0050996) | 3.51252991 |
92 | cholesterol homeostasis (GO:0042632) | 3.49878350 |
93 | arginine metabolic process (GO:0006525) | 3.49562331 |
94 | opsonization (GO:0008228) | 3.45872100 |
95 | nicotinamide nucleotide biosynthetic process (GO:0019359) | 3.45239227 |
96 | pyridine nucleotide biosynthetic process (GO:0019363) | 3.45239227 |
97 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 3.43557249 |
98 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 3.43461483 |
99 | sterol homeostasis (GO:0055092) | 3.43121433 |
100 | complement activation (GO:0006956) | 3.42816307 |
101 | neutrophil activation involved in immune response (GO:0002283) | 3.41010890 |
102 | protein activation cascade (GO:0072376) | 3.40936484 |
103 | L-serine metabolic process (GO:0006563) | 3.40519988 |
104 | acute-phase response (GO:0006953) | 3.37157896 |
105 | carboxylic acid catabolic process (GO:0046395) | 3.35684836 |
106 | organic acid catabolic process (GO:0016054) | 3.35684836 |
107 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.35426014 |
108 | complement activation, classical pathway (GO:0006958) | 3.33750057 |
109 | negative regulation of lipase activity (GO:0060192) | 3.31193850 |
110 | N-acetylneuraminate metabolic process (GO:0006054) | 3.29592496 |
111 | endothelium development (GO:0003158) | 3.28480718 |
112 | NAD biosynthetic process (GO:0009435) | 3.27564180 |
113 | female mating behavior (GO:0060180) | 3.27432879 |
114 | pinocytosis (GO:0006907) | 3.24935380 |
115 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.22875047 |
116 | purine nucleotide salvage (GO:0032261) | 3.21272282 |
117 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.21008023 |
118 | positive regulation of mast cell degranulation (GO:0043306) | 3.21008023 |
119 | purine deoxyribonucleotide catabolic process (GO:0009155) | 3.16319222 |
120 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 3.14750713 |
121 | regulation of hypersensitivity (GO:0002883) | 3.08344105 |
122 | deoxyribonucleotide catabolic process (GO:0009264) | 3.07266419 |
123 | oligosaccharide catabolic process (GO:0009313) | 3.05186930 |
124 | hyperosmotic salinity response (GO:0042538) | 3.04581483 |
125 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.03968739 |
126 | regulation of plasminogen activation (GO:0010755) | 3.00824098 |
127 | amino sugar catabolic process (GO:0046348) | 2.99555634 |
128 | regulation of fatty acid biosynthetic process (GO:0042304) | 2.97309393 |
129 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.97125722 |
130 | positive regulation of systemic arterial blood pressure (GO:0003084) | 2.94244760 |
131 | doxorubicin metabolic process (GO:0044598) | 2.94107811 |
132 | daunorubicin metabolic process (GO:0044597) | 2.94107811 |
133 | polyketide metabolic process (GO:0030638) | 2.94107811 |
134 | response to peptidoglycan (GO:0032494) | 2.92957537 |
135 | mature B cell differentiation involved in immune response (GO:0002313) | 2.92809285 |
136 | detection of bacterium (GO:0016045) | 2.89865605 |
137 | positive regulation of hemostasis (GO:1900048) | 2.88385700 |
138 | positive regulation of blood coagulation (GO:0030194) | 2.88385700 |
139 | positive regulation of prostaglandin secretion (GO:0032308) | 2.87707665 |
140 | deoxyribose phosphate catabolic process (GO:0046386) | 2.87347793 |
141 | positive regulation of megakaryocyte differentiation (GO:0045654) | 2.85006849 |
142 | pyrimidine nucleotide catabolic process (GO:0006244) | 2.83135631 |
143 | positive regulation of antigen processing and presentation (GO:0002579) | 2.82769996 |
144 | regulation of female receptivity (GO:0045924) | 2.80159070 |
145 | sterol catabolic process (GO:0016127) | 2.80117938 |
146 | cholesterol catabolic process (GO:0006707) | 2.80117938 |
147 | positive regulation of mast cell activation (GO:0033005) | 2.79438137 |
148 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.79192531 |
149 | autophagic vacuole fusion (GO:0000046) | 2.78387304 |
150 | detection of other organism (GO:0098543) | 2.78049317 |
151 | B cell mediated immunity (GO:0019724) | 2.76797623 |
152 | regulation of monocyte differentiation (GO:0045655) | 2.76398591 |
153 | negative regulation of digestive system process (GO:0060457) | 2.75835088 |
154 | regulation of leukocyte degranulation (GO:0043300) | 2.71663739 |
155 | negative regulation of blood coagulation (GO:0030195) | 2.71087429 |
156 | negative regulation of hemostasis (GO:1900047) | 2.71087429 |
157 | regulation of prostaglandin secretion (GO:0032306) | 2.70672643 |
158 | sodium-independent organic anion transport (GO:0043252) | 2.68658626 |
159 | definitive hemopoiesis (GO:0060216) | 2.67693483 |
160 | nucleotide salvage (GO:0043173) | 2.67285123 |
161 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.66982771 |
162 | regulation of lipoprotein particle clearance (GO:0010984) | 2.65632427 |
Rank | Gene Set | Z-score |
---|---|---|
1 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 7.01764282 |
2 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 6.30264298 |
3 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 5.88587680 |
4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 5.25337807 |
5 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.77906678 |
6 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.67697268 |
7 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.40726377 |
8 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.08366499 |
9 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.93601911 |
10 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.06018476 |
11 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.37184590 |
12 | * NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.00913678 |
13 | * HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.00641902 |
14 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 10.3493984 |
15 | MYC_22102868_ChIP-Seq_BL_Human | 1.94533314 |
16 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.93983038 |
17 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.88428029 |
18 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.82585767 |
19 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.81411397 |
20 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.79257138 |
21 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.78067851 |
22 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.69298519 |
23 | GATA1_22025678_ChIP-Seq_K562_Human | 1.66121970 |
24 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.65897326 |
25 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.58830786 |
26 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.57856058 |
27 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.53706074 |
28 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.50964212 |
29 | P68_20966046_ChIP-Seq_HELA_Human | 1.49092637 |
30 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.48087414 |
31 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.46609649 |
32 | SPI1_23127762_ChIP-Seq_K562_Human | 1.46011679 |
33 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.42906534 |
34 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.42839432 |
35 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.41856376 |
36 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.41625932 |
37 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.40213236 |
38 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.39005969 |
39 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.35049036 |
40 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.33609747 |
41 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.32536567 |
42 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.32198252 |
43 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.28337143 |
44 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.28129209 |
45 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.27610731 |
46 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.24915565 |
47 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.24275220 |
48 | MAF_26560356_Chip-Seq_TH2_Human | 1.23979205 |
49 | * SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.23937232 |
50 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.23486821 |
51 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.22123596 |
52 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.19198647 |
53 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.15839009 |
54 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.15472926 |
55 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.15088956 |
56 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.13581711 |
57 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.12987323 |
58 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.11558269 |
59 | * CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.11258908 |
60 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.10371549 |
61 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.10142443 |
62 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.10072143 |
63 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.09416083 |
64 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.08341464 |
65 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.08182210 |
66 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.07135861 |
67 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.05944153 |
68 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.04174188 |
69 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.03923961 |
70 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.03724376 |
71 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.03597922 |
72 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.01799348 |
73 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.01538684 |
74 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 0.99893800 |
75 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 0.99699368 |
76 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.98675047 |
77 | CTCF_21964334_Chip-Seq_Bcells_Human | 0.97699824 |
78 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 0.96741715 |
79 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.96714903 |
80 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 0.95540182 |
81 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.95039243 |
82 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.93722499 |
83 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.93207689 |
84 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.92545913 |
85 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.91384385 |
86 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.91011370 |
87 | SPI1_23547873_ChIP-Seq_NB4_Human | 0.89143308 |
88 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 0.89007964 |
89 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.88423340 |
90 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.85208300 |
91 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.84001698 |
92 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.83624265 |
93 | AR_21909140_ChIP-Seq_LNCAP_Human | 0.83338357 |
94 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.82475875 |
95 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.82443660 |
96 | VDR_24763502_ChIP-Seq_THP-1_Human | 0.81825553 |
97 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 0.81506006 |
98 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.80958001 |
99 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.80719581 |
100 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.80604823 |
101 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.80100247 |
102 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 0.78852310 |
103 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.78692401 |
104 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.78329221 |
105 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.77434216 |
106 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.77369660 |
107 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.77259260 |
108 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.77204569 |
109 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.75387608 |
110 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.75363090 |
111 | * GATA4_25053715_ChIP-Seq_YYC3_Human | 0.74422369 |
112 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.72175695 |
113 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.70377668 |
114 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.70055199 |
115 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.67682541 |
116 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.67123211 |
117 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.66961769 |
118 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.66683225 |
119 | * UTX_26944678_Chip-Seq_JUKART_Human | 0.66334249 |
120 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.66317576 |
121 | MAF_26560356_Chip-Seq_TH1_Human | 0.66241977 |
122 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.65889322 |
123 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.65742898 |
124 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.64246160 |
125 | * BCL6_27268052_Chip-Seq_Bcells_Human | 0.64205835 |
126 | MYB_26560356_Chip-Seq_TH1_Human | 0.63397776 |
127 | GATA1_19941826_ChIP-Seq_K562_Human | 0.61598875 |
128 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.61112087 |
129 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.60778540 |
130 | GATA2_19941826_ChIP-Seq_K562_Human | 0.60773612 |
131 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.60159113 |
132 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 0.59811755 |
133 | P300_27268052_Chip-Seq_Bcells_Human | 0.59433487 |
134 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 0.59251895 |
135 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.57995440 |
136 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.57716459 |
137 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.57637005 |
138 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.57438988 |
139 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.57292955 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0002139_abnormal_hepatobiliary_system | 7.03923126 |
2 | MP0005360_urolithiasis | 6.81786360 |
3 | MP0005085_abnormal_gallbladder_physiolo | 5.49875393 |
4 | MP0005365_abnormal_bile_salt | 5.34546762 |
5 | MP0003806_abnormal_nucleotide_metabolis | 4.42076003 |
6 | MP0008875_abnormal_xenobiotic_pharmacok | 4.36127521 |
7 | MP0009840_abnormal_foam_cell | 3.52955201 |
8 | MP0010329_abnormal_lipoprotein_level | 3.40056828 |
9 | MP0003252_abnormal_bile_duct | 3.11856608 |
10 | MP0003191_abnormal_cellular_cholesterol | 2.80737650 |
11 | MP0005083_abnormal_biliary_tract | 2.56430902 |
12 | MP0005332_abnormal_amino_acid | 2.43279905 |
13 | MP0009278_abnormal_bone_marrow | 2.31660553 |
14 | MP0001666_abnormal_nutrient_absorption | 2.30128228 |
15 | MP0003195_calcinosis | 2.25497833 |
16 | MP0002148_abnormal_hypersensitivity_rea | 2.24960483 |
17 | MP0000609_abnormal_liver_physiology | 2.10281912 |
18 | MP0003436_decreased_susceptibility_to | 2.02360144 |
19 | MP0001764_abnormal_homeostasis | 2.01633901 |
20 | MP0002118_abnormal_lipid_homeostasis | 1.91697567 |
21 | MP0005319_abnormal_enzyme/_coenzyme | 1.87630442 |
22 | MP0004019_abnormal_vitamin_homeostasis | 1.86731094 |
23 | MP0003656_abnormal_erythrocyte_physiolo | 1.82897802 |
24 | MP0006082_CNS_inflammation | 1.77508352 |
25 | MP0005000_abnormal_immune_tolerance | 1.68535579 |
26 | MP0003303_peritoneal_inflammation | 1.67001276 |
27 | MP0003186_abnormal_redox_activity | 1.60013274 |
28 | MP0009333_abnormal_splenocyte_physiolog | 1.56772758 |
29 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.54089796 |
30 | MP0001790_abnormal_immune_system | 1.53416827 |
31 | MP0005387_immune_system_phenotype | 1.53416827 |
32 | MP0002452_abnormal_antigen_presenting | 1.47944481 |
33 | MP0005464_abnormal_platelet_physiology | 1.46538161 |
34 | MP0002723_abnormal_immune_serum | 1.44423294 |
35 | MP0001800_abnormal_humoral_immune | 1.39665116 |
36 | MP0002138_abnormal_hepatobiliary_system | 1.38865018 |
37 | MP0003724_increased_susceptibility_to | 1.36587769 |
38 | MP0005671_abnormal_response_to | 1.35755556 |
39 | MP0009764_decreased_sensitivity_to | 1.34652681 |
40 | MP0003868_abnormal_feces_composition | 1.33809886 |
41 | MP0002420_abnormal_adaptive_immunity | 1.33595347 |
42 | MP0001819_abnormal_immune_cell | 1.33344524 |
43 | MP0003011_delayed_dark_adaptation | 1.30785887 |
44 | MP0009697_abnormal_copulation | 1.30552820 |
45 | MP0009785_altered_susceptibility_to | 1.28980663 |
46 | MP0000598_abnormal_liver_morphology | 1.26864958 |
47 | MP0002419_abnormal_innate_immunity | 1.26617717 |
48 | MP0008469_abnormal_protein_level | 1.25494536 |
49 | MP0009643_abnormal_urine_homeostasis | 1.23182493 |
50 | MP0009763_increased_sensitivity_to | 1.21886473 |
51 | MP0000604_amyloidosis | 1.21409551 |
52 | MP0005451_abnormal_body_composition | 1.21305103 |
53 | MP0002405_respiratory_system_inflammati | 1.15102604 |
54 | MP0002837_dystrophic_cardiac_calcinosis | 1.11716591 |
55 | MP0000689_abnormal_spleen_morphology | 1.10839837 |
56 | MP0001853_heart_inflammation | 1.08413998 |
57 | MP0000716_abnormal_immune_system | 1.07154743 |
58 | MP0010386_abnormal_urinary_bladder | 1.06107811 |
59 | MP0002398_abnormal_bone_marrow | 1.05546870 |
60 | MP0001533_abnormal_skeleton_physiology | 1.00408662 |
61 | MP0005025_abnormal_response_to | 0.99452384 |
62 | MP0005310_abnormal_salivary_gland | 0.98374387 |
63 | MP0005376_homeostasis/metabolism_phenot | 0.97198583 |
64 | MP0003705_abnormal_hypodermis_morpholog | 0.97173529 |
65 | MP0001851_eye_inflammation | 0.96901215 |
66 | MP0002429_abnormal_blood_cell | 0.95896621 |
67 | MP0006036_abnormal_mitochondrial_physio | 0.95328334 |
68 | MP0005636_abnormal_mineral_homeostasis | 0.94398955 |
69 | MP0002722_abnormal_immune_system | 0.94270035 |
70 | MP0005645_abnormal_hypothalamus_physiol | 0.94257774 |
71 | MP0003075_altered_response_to | 0.92380707 |
72 | MP0009642_abnormal_blood_homeostasis | 0.90451939 |
73 | MP0001845_abnormal_inflammatory_respons | 0.88423337 |
74 | MP0001663_abnormal_digestive_system | 0.85676717 |
75 | MP0005058_abnormal_lysosome_morphology | 0.84993302 |
76 | MP0009765_abnormal_xenobiotic_induced | 0.82482176 |
77 | MP0003718_maternal_effect | 0.82123664 |
78 | MP0005397_hematopoietic_system_phenotyp | 0.79723058 |
79 | MP0001545_abnormal_hematopoietic_system | 0.79723058 |
80 | MP0004883_abnormal_blood_vessel | 0.78748156 |
81 | MP0003866_abnormal_defecation | 0.78525319 |
82 | MP0005408_hypopigmentation | 0.77644715 |
83 | MP0003329_amyloid_beta_deposits | 0.74333854 |
84 | MP0003172_abnormal_lysosome_physiology | 0.74299630 |
85 | MP0005670_abnormal_white_adipose | 0.74202620 |
86 | MP0005165_increased_susceptibility_to | 0.74198832 |
87 | MP0002971_abnormal_brown_adipose | 0.74080867 |
88 | MP0005164_abnormal_response_to | 0.72993254 |
89 | MP0009053_abnormal_anal_canal | 0.72687603 |
90 | MP0005023_abnormal_wound_healing | 0.71970836 |
91 | MP0004808_abnormal_hematopoietic_stem | 0.69475214 |
92 | MP0005266_abnormal_metabolism | 0.69393381 |
93 | MP0005647_abnormal_sex_gland | 0.68913687 |
94 | MP0002166_altered_tumor_susceptibility | 0.68542474 |
95 | MP0002998_abnormal_bone_remodeling | 0.65387619 |
96 | MP0005410_abnormal_fertilization | 0.64690112 |
97 | MP0001661_extended_life_span | 0.63280749 |
98 | MP0000343_altered_response_to | 0.62784967 |
99 | MP0004264_abnormal_extraembryonic_tissu | 0.62437146 |
100 | MP0008873_increased_physiological_sensi | 0.62055314 |
101 | MP0002089_abnormal_postnatal_growth/wei | 0.61879415 |
102 | MP0003183_abnormal_peptide_metabolism | 0.61372937 |
103 | MP0000249_abnormal_blood_vessel | 0.60919761 |
104 | MP0005334_abnormal_fat_pad | 0.60622919 |
105 | MP0008260_abnormal_autophagy | 0.60147593 |
106 | MP0005166_decreased_susceptibility_to | 0.59905610 |
107 | MP0006054_spinal_hemorrhage | 0.59805069 |
108 | MP0002078_abnormal_glucose_homeostasis | 0.59513148 |
109 | MP0005220_abnormal_exocrine_pancreas | 0.59078707 |
110 | MP0003638_abnormal_response/metabolism_ | 0.58741495 |
111 | MP0002254_reproductive_system_inflammat | 0.58677532 |
112 | MP0003300_gastrointestinal_ulcer | 0.57969996 |
113 | MP0006035_abnormal_mitochondrial_morpho | 0.56989526 |
114 | MP0005075_abnormal_melanosome_morpholog | 0.56908588 |
115 | MP0002876_abnormal_thyroid_physiology | 0.56366714 |
116 | MP0004381_abnormal_hair_follicle | 0.55345432 |
117 | MP0008874_decreased_physiological_sensi | 0.55089089 |
118 | MP0000685_abnormal_immune_system | 0.55066277 |
119 | MP0005167_abnormal_blood-brain_barrier | 0.54571253 |
120 | MP0000858_altered_metastatic_potential | 0.52021878 |
121 | MP0010155_abnormal_intestine_physiology | 0.51797647 |
122 | MP0001835_abnormal_antigen_presentation | 0.51675621 |
123 | MP0001756_abnormal_urination | 0.51544940 |
124 | MP0004782_abnormal_surfactant_physiolog | 0.51503509 |
125 | MP0005535_abnormal_body_temperature | 0.51117175 |
126 | MP0005084_abnormal_gallbladder_morpholo | 0.50397703 |
127 | MP0003690_abnormal_glial_cell | 0.49948057 |
128 | MP0000639_abnormal_adrenal_gland | 0.49555444 |
129 | MP0002396_abnormal_hematopoietic_system | 0.48799355 |
130 | MP0000465_gastrointestinal_hemorrhage | 0.47823363 |
131 | MP0002132_abnormal_respiratory_system | 0.46917699 |
132 | MP0002136_abnormal_kidney_physiology | 0.46890705 |
133 | MP0002060_abnormal_skin_morphology | 0.46141897 |
134 | MP0002970_abnormal_white_adipose | 0.44261769 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Deep venous thrombosis (HP:0002625) | 6.67758229 |
2 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 6.20220126 |
3 | Intrahepatic cholestasis (HP:0001406) | 6.15954688 |
4 | Prolonged partial thromboplastin time (HP:0003645) | 6.14363239 |
5 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 5.89578190 |
6 | Hypobetalipoproteinemia (HP:0003563) | 5.70892237 |
7 | Xanthomatosis (HP:0000991) | 5.70241813 |
8 | Hyperlipoproteinemia (HP:0010980) | 5.04610625 |
9 | Joint hemorrhage (HP:0005261) | 4.79656863 |
10 | Abnormality of the common coagulation pathway (HP:0010990) | 4.77520089 |
11 | Complement deficiency (HP:0004431) | 4.66782322 |
12 | Purpura (HP:0000979) | 4.43991133 |
13 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.22149058 |
14 | Increased cerebral lipofuscin (HP:0011813) | 4.20514798 |
15 | Hypolipoproteinemia (HP:0010981) | 4.17299700 |
16 | Hyperammonemia (HP:0001987) | 4.14286338 |
17 | Abnormality of glycolipid metabolism (HP:0010969) | 4.11673091 |
18 | Abnormality of liposaccharide metabolism (HP:0010968) | 4.11673091 |
19 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 4.11673091 |
20 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 4.01259691 |
21 | Hypoglycemic coma (HP:0001325) | 3.89797542 |
22 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.89190845 |
23 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.87097138 |
24 | Abnormality of the intrinsic pathway (HP:0010989) | 3.79753428 |
25 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.70889557 |
26 | Hyperglycinemia (HP:0002154) | 3.69206474 |
27 | Abnormality of methionine metabolism (HP:0010901) | 3.67549254 |
28 | Ketosis (HP:0001946) | 3.64724976 |
29 | Abnormality of complement system (HP:0005339) | 3.61413898 |
30 | Myositis (HP:0100614) | 3.60047966 |
31 | Fat malabsorption (HP:0002630) | 3.59525897 |
32 | Prolonged bleeding time (HP:0003010) | 3.58050271 |
33 | Epidermoid cyst (HP:0200040) | 3.55585012 |
34 | Hypoalphalipoproteinemia (HP:0003233) | 3.51305854 |
35 | Petechiae (HP:0000967) | 3.50514989 |
36 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.50347262 |
37 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.49960245 |
38 | Obstructive lung disease (HP:0006536) | 3.47210964 |
39 | Chronic obstructive pulmonary disease (HP:0006510) | 3.47210964 |
40 | Dysostosis multiplex (HP:0000943) | 3.46426533 |
41 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.45626726 |
42 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.40306228 |
43 | Abnormality of glycine metabolism (HP:0010895) | 3.40306228 |
44 | Hyperglycinuria (HP:0003108) | 3.34910855 |
45 | Vacuolated lymphocytes (HP:0001922) | 3.33543464 |
46 | Hyperbilirubinemia (HP:0002904) | 3.33083177 |
47 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.30217471 |
48 | Conjugated hyperbilirubinemia (HP:0002908) | 3.23287514 |
49 | Stomatitis (HP:0010280) | 3.17627449 |
50 | Hypercholesterolemia (HP:0003124) | 3.17103171 |
51 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.90477307 |
52 | Abnormality of macrophages (HP:0004311) | 2.89276962 |
53 | Abnormality of nucleobase metabolism (HP:0010932) | 2.87778571 |
54 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.83564504 |
55 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.83564504 |
56 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.83564504 |
57 | Orchitis (HP:0100796) | 2.81782871 |
58 | Delayed CNS myelination (HP:0002188) | 2.79795828 |
59 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.79365873 |
60 | Dicarboxylic aciduria (HP:0003215) | 2.79365873 |
61 | Systemic lupus erythematosus (HP:0002725) | 2.77902517 |
62 | Amyloidosis (HP:0011034) | 2.76982702 |
63 | Steatorrhea (HP:0002570) | 2.74139332 |
64 | Mucopolysacchariduria (HP:0008155) | 2.74080465 |
65 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.74080465 |
66 | Gingival bleeding (HP:0000225) | 2.72612929 |
67 | Loss of speech (HP:0002371) | 2.71391850 |
68 | Mediastinal lymphadenopathy (HP:0100721) | 2.68341166 |
69 | Hepatocellular carcinoma (HP:0001402) | 2.68319199 |
70 | Abnormality of serum amino acid levels (HP:0003112) | 2.62506108 |
71 | Thrombophlebitis (HP:0004418) | 2.60936408 |
72 | Myocardial infarction (HP:0001658) | 2.59139307 |
73 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.58739594 |
74 | Hypertensive crisis (HP:0100735) | 2.55807530 |
75 | Spontaneous abortion (HP:0005268) | 2.53933113 |
76 | Eczematoid dermatitis (HP:0000976) | 2.49097004 |
77 | Acanthocytosis (HP:0001927) | 2.48477386 |
78 | Spastic diplegia (HP:0001264) | 2.47602506 |
79 | Mutism (HP:0002300) | 2.47015078 |
80 | Abnormality of iron homeostasis (HP:0011031) | 2.46788311 |
81 | Ketoacidosis (HP:0001993) | 2.44679117 |
82 | Pancreatitis (HP:0001733) | 2.43665258 |
83 | Generalized aminoaciduria (HP:0002909) | 2.43466683 |
84 | Increased muscle lipid content (HP:0009058) | 2.43043532 |
85 | Hypochromic microcytic anemia (HP:0004840) | 2.42781085 |
86 | Hepatosplenomegaly (HP:0001433) | 2.41770848 |
87 | Metabolic acidosis (HP:0001942) | 2.39505978 |
88 | Agammaglobulinemia (HP:0004432) | 2.39021714 |
89 | Abnormality of purine metabolism (HP:0004352) | 2.38119287 |
90 | Meningitis (HP:0001287) | 2.37237127 |
91 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.34977342 |
92 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.34893103 |
93 | Opisthotonus (HP:0002179) | 2.34309742 |
94 | Retrobulbar optic neuritis (HP:0100654) | 2.31552230 |
95 | Optic neuritis (HP:0100653) | 2.31552230 |
96 | Panhypogammaglobulinemia (HP:0003139) | 2.31074381 |
97 | Recurrent bacterial skin infections (HP:0005406) | 2.30986377 |
98 | Increased intramyocellular lipid droplets (HP:0012240) | 2.30939319 |
99 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 2.30315652 |
100 | Cellulitis (HP:0100658) | 2.28241112 |
101 | Lethargy (HP:0001254) | 2.27854791 |
102 | Vascular calcification (HP:0004934) | 2.26623913 |
103 | Prolonged neonatal jaundice (HP:0006579) | 2.26306825 |
104 | Spastic paraparesis (HP:0002313) | 2.24872530 |
105 | Recurrent fungal infections (HP:0002841) | 2.23441528 |
106 | Skin nodule (HP:0200036) | 2.23302513 |
107 | Autoimmune thrombocytopenia (HP:0001973) | 2.22990892 |
108 | Menorrhagia (HP:0000132) | 2.22193473 |
109 | Poikilocytosis (HP:0004447) | 2.17252352 |
110 | Pulmonary embolism (HP:0002204) | 2.16611518 |
111 | Epistaxis (HP:0000421) | 2.14870534 |
112 | Glomerulonephritis (HP:0000099) | 2.13298683 |
113 | Abnormal gallbladder morphology (HP:0012437) | 2.12781186 |
114 | Increased serum ferritin (HP:0003281) | 2.12670589 |
115 | Cholelithiasis (HP:0001081) | 2.10965482 |
116 | Thrombocytosis (HP:0001894) | 2.09660626 |
117 | Abnormal gallbladder physiology (HP:0012438) | 2.09566881 |
118 | Cholecystitis (HP:0001082) | 2.09566881 |
119 | Reduced antithrombin III activity (HP:0001976) | 2.05864623 |
120 | Episodic fever (HP:0001954) | 2.04355035 |
121 | Esophageal varix (HP:0002040) | 2.03568633 |
122 | Gangrene (HP:0100758) | 2.03455235 |
123 | Hemorrhage of the eye (HP:0011885) | 2.03225959 |
124 | Cerebral palsy (HP:0100021) | 2.02875950 |
125 | Gout (HP:0001997) | 2.02816116 |
126 | Thoracic kyphosis (HP:0002942) | 2.02455007 |
127 | Cerebral edema (HP:0002181) | 2.02353117 |
128 | Periodontitis (HP:0000704) | 2.02136970 |
129 | Disinhibition (HP:0000734) | 2.00506030 |
130 | Mitral stenosis (HP:0001718) | 2.00472874 |
131 | Upper motor neuron abnormality (HP:0002127) | 2.00355538 |
132 | Recurrent skin infections (HP:0001581) | 2.00087639 |
133 | Malnutrition (HP:0004395) | 1.99937749 |
134 | Progressive neurologic deterioration (HP:0002344) | 1.99511761 |
135 | Cardiovascular calcification (HP:0011915) | 1.98865661 |
136 | Late onset (HP:0003584) | 1.98510745 |
137 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 1.96858950 |
138 | Retinal atrophy (HP:0001105) | 1.96370058 |
139 | Neonatal onset (HP:0003623) | 1.95234146 |
140 | Nausea (HP:0002018) | 1.95028846 |
141 | Irritability (HP:0000737) | 1.94891826 |
142 | Recurrent viral infections (HP:0004429) | 1.94680357 |
143 | Vomiting (HP:0002013) | 1.94288343 |
144 | Urticaria (HP:0001025) | 1.94205712 |
145 | Abnormal platelet volume (HP:0011876) | 1.91384055 |
146 | Hypoglycemic seizures (HP:0002173) | 1.90834142 |
147 | Hypertriglyceridemia (HP:0002155) | 1.90242186 |
148 | Recurrent abscess formation (HP:0002722) | 1.88980024 |
149 | Brushfield spots (HP:0001088) | 1.87945232 |
150 | Abnormal cartilage morphology (HP:0002763) | 1.87381481 |
151 | Arterial thrombosis (HP:0004420) | 1.87099449 |
152 | Xerostomia (HP:0000217) | 1.86485460 |
153 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.85740403 |
154 | Paraparesis (HP:0002385) | 1.85247586 |
155 | Epiphyseal stippling (HP:0010655) | 1.84902339 |
156 | Sensorimotor neuropathy (HP:0007141) | 1.84452781 |
157 | Encephalitis (HP:0002383) | 1.83440267 |
158 | Pulmonary infiltrates (HP:0002113) | 1.82818444 |
159 | Proximal tubulopathy (HP:0000114) | 1.82602096 |
160 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 1.82032141 |
161 | Seborrheic dermatitis (HP:0001051) | 1.81999711 |
162 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 1.80386285 |
163 | Renal cortical cysts (HP:0000803) | 1.78654869 |
164 | Elevated hepatic transaminases (HP:0002910) | 1.78267884 |
Rank | Gene Set | Z-score |
---|---|---|
1 | BCKDK | 5.44287514 |
2 | ERN1 | 4.74399869 |
3 | TAOK3 | 3.49913128 |
4 | NME2 | 3.29287619 |
5 | MAP2K3 | 2.85522708 |
6 | FGFR4 | 2.75238494 |
7 | PKN2 | 2.69062159 |
8 | TRIB3 | 2.62932518 |
9 | IRAK4 | 2.50815173 |
10 | SIK1 | 2.50277529 |
11 | GRK6 | 2.28682271 |
12 | EIF2AK3 | 2.27829952 |
13 | EPHB1 | 2.18102926 |
14 | VRK2 | 2.07888855 |
15 | KDR | 1.82723936 |
16 | TESK2 | 1.75944932 |
17 | FLT3 | 1.74081932 |
18 | BTK | 1.71514798 |
19 | ABL2 | 1.70079465 |
20 | TYK2 | 1.68583461 |
21 | STK16 | 1.68086539 |
22 | MAP3K11 | 1.66718254 |
23 | TEC | 1.60036876 |
24 | MAP3K3 | 1.58662556 |
25 | PIK3CG | 1.57181705 |
26 | BLK | 1.50564486 |
27 | MAPK11 | 1.49246401 |
28 | TGFBR2 | 1.45796305 |
29 | IKBKB | 1.42856264 |
30 | MAPK4 | 1.41779218 |
31 | TNK2 | 1.39238279 |
32 | JAK3 | 1.38277777 |
33 | PTK6 | 1.37398169 |
34 | NEK9 | 1.31740243 |
35 | CCNB1 | 1.31689876 |
36 | PBK | 1.31618756 |
37 | CSK | 1.24597632 |
38 | MAP3K12 | 1.23583925 |
39 | MATK | 1.22696186 |
40 | EPHA2 | 1.20928269 |
41 | FES | 1.19301968 |
42 | TAOK2 | 1.12622342 |
43 | JAK2 | 1.11399263 |
44 | CDK19 | 1.10471592 |
45 | MAP4K1 | 1.10051862 |
46 | ERBB4 | 1.09879155 |
47 | PAK4 | 1.08555380 |
48 | IRAK3 | 1.08074945 |
49 | GRK7 | 1.05601112 |
50 | EIF2AK1 | 1.03286687 |
51 | DYRK1B | 1.02796880 |
52 | TRPM7 | 1.02546769 |
53 | LRRK2 | 1.02496931 |
54 | RIPK4 | 1.01847532 |
55 | WEE1 | 1.01349244 |
56 | MAP2K4 | 1.00240383 |
57 | MAP3K6 | 1.00194563 |
58 | TBK1 | 0.98048235 |
59 | ZAP70 | 0.95062631 |
60 | STK10 | 0.95010805 |
61 | LCK | 0.93200404 |
62 | FGR | 0.90815443 |
63 | MAP3K5 | 0.89254338 |
64 | MST1R | 0.86152949 |
65 | ITK | 0.85775930 |
66 | MAP2K6 | 0.84550219 |
67 | MAP3K8 | 0.84295515 |
68 | PRPF4B | 0.84171014 |
69 | PRKD2 | 0.82497438 |
70 | TXK | 0.82319179 |
71 | TESK1 | 0.80176281 |
72 | ARAF | 0.79700672 |
73 | JAK1 | 0.79639122 |
74 | MAP3K10 | 0.77668670 |
75 | CSF1R | 0.76028474 |
76 | EEF2K | 0.75582573 |
77 | INSRR | 0.74876605 |
78 | HCK | 0.70435434 |
79 | NUAK1 | 0.69508338 |
80 | DAPK1 | 0.65637387 |
81 | SIK2 | 0.63769845 |
82 | CDK4 | 0.63177175 |
83 | MAP3K14 | 0.62817225 |
84 | PINK1 | 0.60190133 |
85 | TAOK1 | 0.58895823 |
86 | RPS6KB2 | 0.58661939 |
87 | MYLK | 0.56689235 |
88 | PTK2 | 0.54774822 |
89 | SYK | 0.52779602 |
90 | SMG1 | 0.52231344 |
91 | NEK1 | 0.51583919 |
92 | DAPK2 | 0.50172752 |
93 | BMX | 0.49848396 |
94 | MAP2K2 | 0.48163230 |
95 | PRKAA2 | 0.47849879 |
96 | MAPKAPK3 | 0.46982003 |
97 | MAP3K13 | 0.46603346 |
98 | IRAK2 | 0.46567216 |
99 | PIM1 | 0.46284935 |
100 | PRKACG | 0.45166480 |
101 | PRKCD | 0.44850101 |
102 | MAP3K1 | 0.44054136 |
103 | SCYL2 | 0.42084598 |
104 | LYN | 0.41419910 |
105 | KIT | 0.40891010 |
106 | AURKA | 0.40297716 |
107 | DDR2 | 0.40242008 |
108 | CDK6 | 0.39882606 |
109 | MAPK3 | 0.39841688 |
110 | PIM2 | 0.39632229 |
111 | PDPK1 | 0.39558797 |
112 | GRK1 | 0.38732342 |
113 | EIF2AK2 | 0.38218002 |
114 | PRKCZ | 0.37018061 |
115 | CAMK1D | 0.36451371 |
116 | NEK2 | 0.35912188 |
117 | DAPK3 | 0.35686736 |
118 | MARK2 | 0.34994760 |
119 | CAMKK2 | 0.34681497 |
120 | IKBKE | 0.34487365 |
121 | ADRBK2 | 0.33468464 |
122 | PRKG2 | 0.32911647 |
123 | PRKCQ | 0.32677837 |
124 | CDK9 | 0.32072103 |
125 | CAMKK1 | 0.31954445 |
126 | RIPK1 | 0.31504428 |
127 | CDK7 | 0.30898052 |
128 | FRK | 0.29212294 |
129 | RPS6KA5 | 0.29132114 |
130 | CDC42BPA | 0.29074244 |
131 | ABL1 | 0.28403936 |
132 | STK4 | 0.27868777 |
133 | RPS6KC1 | 0.27462967 |
134 | RPS6KL1 | 0.27462967 |
135 | RPS6KA6 | 0.27034872 |
136 | EGFR | 0.26721424 |
137 | CHUK | 0.22735940 |
138 | MAP4K2 | 0.22626033 |
139 | ATR | 0.22196880 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.29496973 |
2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.31341835 |
3 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.26613492 |
4 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.06805673 |
5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.92042989 |
6 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.80339225 |
7 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.68260535 |
8 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.58667467 |
9 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.44356072 |
10 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.39745893 |
11 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.32220884 |
12 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.29632396 |
13 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.27227233 |
14 | Histidine metabolism_Homo sapiens_hsa00340 | 2.24592822 |
15 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.08434621 |
16 | Asthma_Homo sapiens_hsa05310 | 2.07663509 |
17 | Peroxisome_Homo sapiens_hsa04146 | 2.07451125 |
18 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.99531043 |
19 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.85634633 |
20 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.83413377 |
21 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.82932725 |
22 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.80445626 |
23 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.80035549 |
24 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.77767106 |
25 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.72144731 |
26 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.71033498 |
27 | Allograft rejection_Homo sapiens_hsa05330 | 1.69708177 |
28 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.67300972 |
29 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.67155328 |
30 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.64453819 |
31 | Retinol metabolism_Homo sapiens_hsa00830 | 1.59944304 |
32 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.58398174 |
33 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.57965301 |
34 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.57934592 |
35 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.52788122 |
36 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.52574218 |
37 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.45855030 |
38 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.45390697 |
39 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.43327019 |
40 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.42818215 |
41 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.41605632 |
42 | Carbon metabolism_Homo sapiens_hsa01200 | 1.40493863 |
43 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.39557018 |
44 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.38799726 |
45 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.38422022 |
46 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.36547178 |
47 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.28699536 |
48 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.27591836 |
49 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.27574337 |
50 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.24391055 |
51 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.23373957 |
52 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.22083221 |
53 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.22043786 |
54 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.20710262 |
55 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.18332961 |
56 | Sulfur relay system_Homo sapiens_hsa04122 | 1.16323263 |
57 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.16119128 |
58 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.15802911 |
59 | ABC transporters_Homo sapiens_hsa02010 | 1.14466643 |
60 | Bile secretion_Homo sapiens_hsa04976 | 1.12900703 |
61 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.11903277 |
62 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.09746809 |
63 | Base excision repair_Homo sapiens_hsa03410 | 1.08733687 |
64 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.08506792 |
65 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.06804692 |
66 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.06648536 |
67 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.03563074 |
68 | Tuberculosis_Homo sapiens_hsa05152 | 1.02159629 |
69 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.01677124 |
70 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.96827111 |
71 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.94899873 |
72 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.93961743 |
73 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.84771376 |
74 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.84104421 |
75 | Malaria_Homo sapiens_hsa05144 | 0.79752319 |
76 | Lysine degradation_Homo sapiens_hsa00310 | 0.73884422 |
77 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.71824135 |
78 | Galactose metabolism_Homo sapiens_hsa00052 | 0.69598535 |
79 | Phagosome_Homo sapiens_hsa04145 | 0.69131868 |
80 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.69083865 |
81 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.68090329 |
82 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.67992899 |
83 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.65842814 |
84 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.65257031 |
85 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.62072434 |
86 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.61770790 |
87 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.60854080 |
88 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.59526780 |
89 | * Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.57818569 |
90 | Platelet activation_Homo sapiens_hsa04611 | 0.54993595 |
91 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.54781137 |
92 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.53422023 |
93 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.52945647 |
94 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.52545966 |
95 | Metabolic pathways_Homo sapiens_hsa01100 | 0.50416006 |
96 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.50126226 |
97 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.46033304 |
98 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.44167467 |
99 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.43744351 |
100 | Salmonella infection_Homo sapiens_hsa05132 | 0.43150010 |
101 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.42418337 |
102 | Mineral absorption_Homo sapiens_hsa04978 | 0.41416759 |
103 | Viral myocarditis_Homo sapiens_hsa05416 | 0.40084093 |
104 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.32726955 |
105 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.27002391 |
106 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.24248580 |
107 | Insulin resistance_Homo sapiens_hsa04931 | 0.23406763 |
108 | Other glycan degradation_Homo sapiens_hsa00511 | 0.23055893 |
109 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.22200229 |
110 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.16245682 |
111 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.15096805 |
112 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.13508504 |
113 | Leishmaniasis_Homo sapiens_hsa05140 | 0.11886794 |
114 | Prion diseases_Homo sapiens_hsa05020 | 0.11766414 |
115 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.11737901 |
116 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.10209448 |
117 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.03657602 |
118 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.02503995 |
119 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.01337648 |
120 | Lysosome_Homo sapiens_hsa04142 | 0.00118739 |
121 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.0837612 |
122 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | -0.0803086 |
123 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | -0.0795125 |
124 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.0745256 |
125 | Bladder cancer_Homo sapiens_hsa05219 | -0.0546448 |
126 | AMPK signaling pathway_Homo sapiens_hsa04152 | -0.0520625 |
127 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.0437694 |
128 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | -0.0347567 |
129 | Protein export_Homo sapiens_hsa03060 | -0.0216632 |
130 | Linoleic acid metabolism_Homo sapiens_hsa00591 | -0.0206004 |
131 | Legionellosis_Homo sapiens_hsa05134 | -0.0189992 |
132 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | -0.0040100 |
133 | Pertussis_Homo sapiens_hsa05133 | -0.0039472 |
134 | Glucagon signaling pathway_Homo sapiens_hsa04922 | -0.0005317 |